164 related articles for article (PubMed ID: 9878040)
21. gamma-Globulin-induced modulation with necrotic-like morphology of peripheral blood neutrophils.
Sugita K; Hirao J; Arisaka O; Eguchi M
Eur J Pharmacol; 2005 Apr; 513(1-2):141-4. PubMed ID: 15878719
[TBL] [Abstract][Full Text] [Related]
22. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P
J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease.
Ichiyama T; Yoshitomi T; Nishikawa M; Fujiwara M; Matsubara T; Hayashi T; Furukawa S
Clin Immunol; 2001 Jun; 99(3):373-7. PubMed ID: 11358434
[TBL] [Abstract][Full Text] [Related]
24. CD14-dependent airway neutrophil response to inhaled LPS: role of atopy.
Alexis N; Eldridge M; Reed W; Bromberg P; Peden DB
J Allergy Clin Immunol; 2001 Jan; 107(1):31-5. PubMed ID: 11149987
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD11b as an adhesion molecule on neutrophils in children with Kawasaki disease.
Heidari B; Amin R; Kashef S; Alyasin S; Moghtaderi M; Aminshahidi M; Kalani M
Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):265-70. PubMed ID: 24659162
[TBL] [Abstract][Full Text] [Related]
26. Diverging pathways for lipopolysaccharide and CD14 in human monocytes.
Antal-Szalmás P; Poppelier MJ; Broekhuizen R; Verhoef J; van Strijp JA; van Kessel KP
Cytometry; 2000 Dec; 41(4):279-88. PubMed ID: 11084613
[TBL] [Abstract][Full Text] [Related]
27. Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
Kitchens RL; Thompson PA
J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659
[TBL] [Abstract][Full Text] [Related]
28. IC14, a CD14 specific monoclonal antibody, is a potential treatment for patients with severe sepsis.
Axtelle T; Pribble J
J Endotoxin Res; 2001; 7(4):310-4. PubMed ID: 11717588
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury after cardiopulmonary bypass in the rabbit endotoxemia model.
Wakayama F; Fukuda I; Suzuki Y; Kondo N
Ann Thorac Surg; 2007 Jan; 83(1):153-60. PubMed ID: 17184651
[TBL] [Abstract][Full Text] [Related]
30. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds.
Heumann D; Lauener R; Ryffel B
J Endotoxin Res; 2003; 9(6):381-4. PubMed ID: 14733725
[TBL] [Abstract][Full Text] [Related]
31. Bacterial wall products induce downregulation of vascular endothelial growth factor receptors on endothelial cells via a CD14-dependent mechanism: implications for surgical wound healing.
Power C; Wang JH; Sookhai S; Street JT; Redmond HP
J Surg Res; 2001 Dec; 101(2):138-45. PubMed ID: 11735268
[TBL] [Abstract][Full Text] [Related]
32. Serum modulation of neutrophil response to Porphyromonas gingivalis LPS in periodontal disease.
Soolari AS; Champagne C; Punzi JS; Amar S; Van Dyke TE
J Int Acad Periodontol; 1999 Oct; 1(4):101-9. PubMed ID: 12666954
[TBL] [Abstract][Full Text] [Related]
33. The role of tumour necrosis factor in the kinetics of lipopolysaccharide-mediated neutrophil priming in whole blood.
van Leeuwen HJ; Van Der Tol M; Van Strijp JA; Verhoef J; van Kessel KP
Clin Exp Immunol; 2005 Apr; 140(1):65-72. PubMed ID: 15762876
[TBL] [Abstract][Full Text] [Related]
34. Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease.
Chou CT; Chang JS; Ooi SE; Huo AP; Chang SJ; Chang HN; Tsai CY
Arch Med Res; 2005; 36(1):14-8. PubMed ID: 15777989
[TBL] [Abstract][Full Text] [Related]
35. [Kawasaki disease: recent findings in etiology, pathogenesis and therapy].
Di Piero G; Bellisario G; Di Maggio M; Garibaldi G; Isola ML; Pauselli F; Proia R
Pediatr Med Chir; 1989; 11(2):209-17. PubMed ID: 2668907
[TBL] [Abstract][Full Text] [Related]
36. Enhanced formation of neutrophil extracellular traps in Kawasaki disease.
Yoshida Y; Takeshita S; Kawamura Y; Kanai T; Tsujita Y; Nonoyama S
Pediatr Res; 2020 May; 87(6):998-1004. PubMed ID: 31935748
[TBL] [Abstract][Full Text] [Related]
37. Immunological abnormalities in Kawasaki disease.
Okumura K; Jujho K; Yanase Y
Prog Clin Biol Res; 1987; 250():167-74. PubMed ID: 3423036
[No Abstract] [Full Text] [Related]
38. [Plasma interleukin-10 levels in Kawasaki disease].
Hirao J; Hibi S; Andoh T; Ichimura T
Arerugi; 1996 Apr; 45(4):409-12. PubMed ID: 8687289
[TBL] [Abstract][Full Text] [Related]
39. [Evidence for a possible role of the mite antigen in Kawasaki disease].
Furusho K; Sato K; Soeda T; Okabe T; Hirota T
Nihon Rinsho; 1983 Sep; 41(9):2017-22. PubMed ID: 6229653
[No Abstract] [Full Text] [Related]
40. Cytopathogenic protein (CPP) produced by Propionibacterium acnes isolated from patients with Kawasaki disease.
Tomita S; Koga Y; Inoue O; Fujimoto T; Kato H
Prog Clin Biol Res; 1987; 250():73-80. PubMed ID: 3423083
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
